Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Comments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases.

Jorsal A, Persson F, Bruun JM.

Eur Heart J. 2020 Jan 7;41(2):328. doi: 10.1093/eurheartj/ehz777. No abstract available.

PMID:
31803914
2.

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease.

Persson F, Frimodt-Møller M, Rossing P.

Kidney Int Rep. 2019 Aug 20;4(10):1362-1365. doi: 10.1016/j.ekir.2019.08.009. eCollection 2019 Oct. No abstract available.

3.

Mitigating risk of aldosterone in diabetic kidney disease.

Frimodt-Møller M, Persson F, Rossing P.

Curr Opin Nephrol Hypertens. 2020 Jan;29(1):145-151. doi: 10.1097/MNH.0000000000000557.

4.

Clinical validation of a novel automated cell-free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma.

Ericsson O, Ahola T, Dahl F, Karlsson F, Persson F, Karlberg O, Roos F, Alftrén I, Andersson B, Barkenäs E, Boghos A, Brandner B, Dahlberg J, Forsgren PO, Francois N, Gousseva A, Hakamali F, Janfalk-Carlsson Å, Johansson H, Lundgren J, Mohsenchian A, Olausson L, Olofsson S, Qureshi A, Skarpås B, Svahn P, Sävneby A, Åström E, Sahlberg A, Fianu-Jonasson A, Gautier J, Costa JM, Jacobsson B, Nicolaides K.

Prenat Diagn. 2019 Oct;39(11):1011-1015. doi: 10.1002/pd.5528. Epub 2019 Aug 19.

5.

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.

van Raalte DH, Bjornstad P, Persson F, Powell DR, de Cassia Castro R, Wang PS, Liu M, Heerspink HJL, Cherney D.

Diabetes Care. 2019 Oct;42(10):1921-1929. doi: 10.2337/dc19-0937. Epub 2019 Aug 1.

PMID:
31371432
6.

Response to starvation and microbial community composition in microbial fuel cells enriched on different electron donors.

Saheb-Alam S, Persson F, Wilén BM, Hermansson M, Modin O.

Microb Biotechnol. 2019 Sep;12(5):962-975. doi: 10.1111/1751-7915.13449. Epub 2019 Jun 22.

7.

Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.

Vistisen D, Andersen GS, Hulman A, Persson F, Rossing P, Jørgensen ME.

Diabetes Care. 2019 Oct;42(10):1886-1894. doi: 10.2337/dc19-0349. Epub 2019 Jun 20.

PMID:
31221677
8.

Corrigendum to "PAC dosing to an MBBR - Effects on adsorption of micropollutants, nitrification and microbial community" [Sci. Total Environ. 677 (2019) 571-579].

Cimbritz M, Edefell E, Thörnqvist E, El-Taliawy H, Ekenberg M, Burzio C, Modin O, Persson F, Wilén BM, Bester K, Falås P.

Sci Total Environ. 2019 Oct 1;685:1307. doi: 10.1016/j.scitotenv.2019.05.431. Epub 2019 Jun 10. No abstract available.

PMID:
31189502
9.

Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors.

Eickhoff MK, Dekkers CCJ, Kramers BJ, Laverman GD, Frimodt-Møller M, Jørgensen NR, Faber J, Danser AHJ, Gansevoort RT, Rossing P, Persson F, Heerspink HJL.

J Clin Med. 2019 May 31;8(6). pii: E779. doi: 10.3390/jcm8060779.

10.

PAC dosing to an MBBR - Effects on adsorption of micropollutants, nitrification and microbial community.

Cimbritz M, Edefell E, Thörnqvist E, El-Taliawy H, Ekenberg M, Burzio C, Modin O, Persson F, Wilén BM, Bester K, Falås P.

Sci Total Environ. 2019 Aug 10;677:571-579. doi: 10.1016/j.scitotenv.2019.04.261. Epub 2019 Apr 29. Erratum in: Sci Total Environ. 2019 Oct 1;685:1307.

PMID:
31067478
11.

Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin.

Rossing P, Persson F, Frimodt-Møller M.

Kidney Int. 2019 Jun;95(6):1287-1288. doi: 10.1016/j.kint.2019.03.002. Epub 2019 Mar 7. No abstract available.

PMID:
31029502
12.

Combined Deterministic and Stochastic Processes Control Microbial Succession in Replicate Granular Biofilm Reactors.

Liébana R, Modin O, Persson F, Szabó E, Hermansson M, Wilén BM.

Environ Sci Technol. 2019 May 7;53(9):4912-4921. doi: 10.1021/acs.est.8b06669. Epub 2019 Apr 22.

PMID:
30969774
13.

Thickness determines microbial community structure and function in nitrifying biofilms via deterministic assembly.

Suarez C, Piculell M, Modin O, Langenheder S, Persson F, Hermansson M.

Sci Rep. 2019 Mar 25;9(1):5110. doi: 10.1038/s41598-019-41542-1.

14.

Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.

Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.

Diabetes Care. 2019 Jun;42(6):1112-1119. doi: 10.2337/dc18-1427. Epub 2019 Mar 18.

PMID:
30885954
15.

Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study.

Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW.

Endocrinol Diabetes Metab. 2018 Aug 31;1(4):e00036. doi: 10.1002/edm2.36. eCollection 2018 Oct.

16.

A variety of hydrogenotrophic enrichment cultures catalyse cathodic reactions.

Saheb-Alam S, Persson F, Wilén BM, Hermansson M, Modin O.

Sci Rep. 2019 Feb 20;9(1):2356. doi: 10.1038/s41598-018-38006-3.

17.

Subsea tunnel reinforced sprayed concrete subjected to deterioration harbours distinct microbial communities.

Karačić S, Wilén BM, Suarez C, Hagelia P, Persson F.

Biofouling. 2018 Nov;34(10):1161-1174. doi: 10.1080/08927014.2018.1556259. Epub 2019 Feb 10.

PMID:
30740996
18.

Diagnosis of diabetic kidney disease: state of the art and future perspective.

Persson F, Rossing P.

Kidney Int Suppl (2011). 2018 Jan;8(1):2-7. doi: 10.1016/j.kisu.2017.10.003. Epub 2017 Dec 29. Review.

19.

Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder.

Rossing P, Frimodt-Møller M, Persson F.

Am J Kidney Dis. 2019 Mar;73(3):293-296. doi: 10.1053/j.ajkd.2018.11.005. Epub 2019 Jan 18. No abstract available.

PMID:
30665725
20.

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment.

Zobel EH, von Scholten BJ, Goldman B, Persson F, Hansen TW, Rossing P.

Diabetes Obes Metab. 2019 May;21(5):1261-1265. doi: 10.1111/dom.13638. Epub 2019 Feb 22.

21.

Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives.

Persson F, Rossing P.

Proteomics Clin Appl. 2019 Mar;13(2):e1800176. doi: 10.1002/prca.201800176. Epub 2019 Jan 22. Review.

PMID:
30632676
22.

Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.

Oellgaard J, Gæde P, Persson F, Rossing P, Parving HH, Pedersen O.

J Diabetes Complications. 2018 Dec;32(12):1133-1140. doi: 10.1016/j.jdiacomp.2018.09.012. Epub 2018 Sep 24.

PMID:
30282584
23.

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.

Rotbain Curovic V, Hansen TW, Eickhoff MK, von Scholten BJ, Reinhard H, Jacobsen PK, Persson F, Parving HH, Rossing P.

Acta Diabetol. 2018 Nov;55(11):1143-1150. doi: 10.1007/s00592-018-1205-0. Epub 2018 Aug 14.

PMID:
30105469
24.

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Idzerda NMA, Persson F, Pena MJ, Brenner BM, Brunel P, Chaturvedi N, McMurray JJ, Parving HH, de Zeeuw D, Heerspink HJL.

Diabetes Obes Metab. 2018 Dec;20(12):2899-2904. doi: 10.1111/dom.13465. Epub 2018 Aug 5.

25.

Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database.

Borg R, Persson F, Siersma V, Lind B, de Fine Olivarius N, Andersen CL.

Diabet Med. 2018 Dec;35(12):1700-1706. doi: 10.1111/dme.13776. Epub 2018 Aug 20.

PMID:
29985535
26.

The geometry of protein hydration.

Persson F, Söderhjelm P, Halle B.

J Chem Phys. 2018 Jun 7;148(21):215101. doi: 10.1063/1.5026744.

PMID:
29884063
27.

Compressibility of the protein-water interface.

Persson F, Halle B.

J Chem Phys. 2018 Jun 7;148(21):215102. doi: 10.1063/1.5026774.

PMID:
29884062
28.

The spatial range of protein hydration.

Persson F, Söderhjelm P, Halle B.

J Chem Phys. 2018 Jun 7;148(21):215104. doi: 10.1063/1.5031005.

PMID:
29884061
29.

How proteins modify water dynamics.

Persson F, Söderhjelm P, Halle B.

J Chem Phys. 2018 Jun 7;148(21):215103. doi: 10.1063/1.5026861.

PMID:
29884055
30.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

Tofte N, Lindhardt M, Adamova K, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti PL, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H, Rossing P.

Diabet Med. 2018 Oct;35(10):1375-1382. doi: 10.1111/dme.13669. Epub 2018 Jun 6.

PMID:
29781558
31.

Aldosterone Blockade Added to Renin-Angiotensin System Blockade to Reduce Albuminuria-A Path for Improved Renoprotection?

Rossing P, Persson F.

Am J Med Sci. 2018 May;355(5):407-408. doi: 10.1016/j.amjms.2018.01.012. Epub 2018 Feb 7. No abstract available.

PMID:
29753367
32.

The mechanisms of granulation of activated sludge in wastewater treatment, its optimization, and impact on effluent quality.

Wilén BM, Liébana R, Persson F, Modin O, Hermansson M.

Appl Microbiol Biotechnol. 2018 Jun;102(12):5005-5020. doi: 10.1007/s00253-018-8990-9. Epub 2018 Apr 28. Review.

33.

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.

Frimodt-Møller M, von Scholten BJ, Reinhard H, Jacobsen PK, Hansen TW, Persson FI, Parving HH, Rossing P.

PLoS One. 2018 Apr 26;13(4):e0196634. doi: 10.1371/journal.pone.0196634. eCollection 2018.

34.

Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes.

Pilemann-Lyberg S, Hansen TW, Persson F, Theilade S, Singh Ahluwalia T, Frystyk J, Rossing P.

Nephrol Dial Transplant. 2019 Apr 1;34(4):659-666. doi: 10.1093/ndt/gfy076.

PMID:
29660007
35.

Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives.

Rossing P, Persson F, Frimodt-Møller M.

Nephrol Ther. 2018 Apr;14 Suppl 1:S31-S37. doi: 10.1016/j.nephro.2018.02.007.

PMID:
29606261
36.

Imaging single DNA molecules for high precision NIPT.

Dahl F, Ericsson O, Karlberg O, Karlsson F, Howell M, Persson F, Roos F, Stenberg J, Ahola T, Alftrén I, Andersson B, Barkenäs E, Brandner B, Dahlberg J, Elfman S, Eriksson M, Forsgren PO, Francois N, Gousseva A, Hakamali F, Janfalk-Carlsson Å, Johansson H, Lundgren J, Mohsenchian A, Olausson L, Olofsson S, Qureshi A, Skarpås B, Sävneby A, Åström E, Öhman O, Westgren M, Kopp-Kallner H, Fianu-Jonasson A, Syngelaki A, Nicolaides K.

Sci Rep. 2018 Mar 14;8(1):4549. doi: 10.1038/s41598-018-22606-0.

37.

Serum uric acid and progression of diabetic nephropathy in type 1 diabetes.

Pilemann-Lyberg S, Lindhardt M, Persson F, Andersen S, Rossing P.

J Diabetes Complications. 2018 May;32(5):470-473. doi: 10.1016/j.jdiacomp.2018.02.002. Epub 2018 Feb 15.

PMID:
29534864
38.

Integration of aerobic granular sludge and membrane bioreactors for wastewater treatment.

Liébana R, Modin O, Persson F, Wilén BM.

Crit Rev Biotechnol. 2018 Sep;38(6):801-816. doi: 10.1080/07388551.2017.1414140. Epub 2018 Feb 4. Review.

PMID:
29400086
39.

The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial.

Pilemann-Lyberg S, Persson F, Frystyk J, Rossing P.

Diabet Med. 2018 Mar;35(3):392-393. doi: 10.1111/dme.13577. No abstract available.

PMID:
29315768
40.

YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.

Persson F, Borg R.

Kidney Int. 2018 Jan;93(1):21-22. doi: 10.1016/j.kint.2017.08.009.

PMID:
29291818
41.

Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial.

Borg R, Persson F.

Ann Transl Med. 2017 Dec;5(23):478. doi: 10.21037/atm.2017.11.02. No abstract available.

42.

Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis.

Nyqvist J, Persson F, Parris TZ, Helou K, Kenne Sarenmalm E, Einbeigi Z, Borg Å, Karlsson P, Kovács A.

Case Rep Oncol. 2017 Nov 16;10(3):1006-1012. doi: 10.1159/000484403. eCollection 2017 Sep-Dec.

43.

Effect of Start-Up Strategies and Electrode Materials on Carbon Dioxide Reduction on Biocathodes.

Saheb-Alam S, Singh A, Hermansson M, Persson F, Schnürer A, Wilén BM, Modin O.

Appl Environ Microbiol. 2018 Jan 31;84(4). pii: e02242-17. doi: 10.1128/AEM.02242-17. Print 2018 Feb 15.

44.

The risk of symptomatic knee osteoarthritis after arthroscopic meniscus repair vs partial meniscectomy vs the general population.

Persson F, Turkiewicz A, Bergkvist D, Neuman P, Englund M.

Osteoarthritis Cartilage. 2018 Feb;26(2):195-201. doi: 10.1016/j.joca.2017.08.020. Epub 2017 Nov 14.

45.

Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.

Petrykiv SI, Laverman GD, Persson F, Vogt L, Rossing P, de Borst MH, Gansevoort RT, de Zeeuw D, Heerspink HJL.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1804-1813. doi: 10.2215/CJN.00390117. Epub 2017 Oct 11. Review.

46.

Fluorescence Microscopy of Nanochannel-Confined DNA.

Westerlund F, Persson F, Fritzsche J, Beech JP, Tegenfeldt JO.

Methods Mol Biol. 2018;1665:173-198. doi: 10.1007/978-1-4939-7271-5_10.

PMID:
28940070
47.

Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast.

Kovács A, Persson F, Persson M, Andersson MK, Stenman G.

Mol Clin Oncol. 2017 Sep;7(3):322-326. doi: 10.3892/mco.2017.1330. Epub 2017 Jul 18.

48.

Comparison of the bacterial community composition in the granular and the suspended phase of sequencing batch reactors.

Szabó E, Liébana R, Hermansson M, Modin O, Persson F, Wilén BM.

AMB Express. 2017 Sep 5;7(1):168. doi: 10.1186/s13568-017-0471-5.

49.

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.

Birkeland KI, Jørgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nyström T, Eriksson JW, Bodegård J, Norhammar A.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):709-717. doi: 10.1016/S2213-8587(17)30258-9. Epub 2017 Aug 3.

PMID:
28781064
50.

Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study.

Persson F, Nyström T, Jørgensen ME, Carstensen B, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Eriksson JW, Norhammar A, Bodegard J, Birkeland KI.

Diabetes Obes Metab. 2018 Feb;20(2):344-351. doi: 10.1111/dom.13077. Epub 2017 Sep 8.

Supplemental Content

Loading ...
Support Center